- Home
- ETON vs STRW Comparison
ETON vs STRW Comparison
Compare ETON & STRW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETON
- STRW
- Stock Information
- Founded
- ETON 2017
- STRW 2015
- Country
- ETON United States
- STRW United States
- Employees
- ETON N/A
- STRW N/A
- Industry
- ETON Biotechnology: Pharmaceutical Preparations
- STRW Real Estate Investment Trusts
- Sector
- ETON Health Care
- STRW Real Estate
- Exchange
- ETON Nasdaq
- STRW Nasdaq
- Market Cap
- ETON 199.5M
- STRW 79.7M
- IPO Year
- ETON 2018
- STRW N/A
- Fundamental
- Price
- ETON $8.82
- STRW $12.52
- Analyst Decision
- ETON Strong Buy
- STRW Strong Buy
- Analyst Count
- ETON 3
- STRW 1
- Target Price
- ETON $12.00
- STRW $10.00
- AVG Volume (30 Days)
- ETON 214.1K
- STRW 14.4K
- Earning Date
- ETON 11-11-2024
- STRW 11-11-2024
- Dividend Yield
- ETON N/A
- STRW 4.11%
- EPS Growth
- ETON N/A
- STRW N/A
- EPS
- ETON N/A
- STRW 0.47
- Revenue
- ETON $31,381,000.00
- STRW $108,357,000.00
- Revenue This Year
- ETON $19.61
- STRW N/A
- Revenue Next Year
- ETON $35.39
- STRW N/A
- P/E Ratio
- ETON N/A
- STRW $27.19
- Revenue Growth
- ETON 8.14
- STRW 12.45
- 52 Week Low
- ETON $3.03
- STRW $6.56
- 52 Week High
- ETON $8.66
- STRW $12.90
- Technical
- Relative Strength Index (RSI)
- ETON 76.07
- STRW 62.39
- Support Level
- ETON $7.58
- STRW $11.57
- Resistance Level
- ETON $8.66
- STRW $12.36
- Average True Range (ATR)
- ETON 0.42
- STRW 0.32
- MACD
- ETON -0.07
- STRW 0.05
- Stochastic Oscillator
- ETON 91.49
- STRW 93.10
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About STRW Strawberry Fields REIT Inc.
Strawberry Fields REIT Inc is a self-managed and self-administered company that specializes in the acquisition, ownership and triple-net leasing of skilled nursing facilities and other post-acute healthcare properties.